Trustmark National Bank Trust Department’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Trustmark National Bank Trust Department’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100	Closed	-$17K	–	585
2019 Q2	$17K	Hold	100	–	–	﹤0.01%	434
2019 Q1	$17K	Hold	100	–	–	﹤0.01%	430
2018 Q4	$10K	Buy	+100	New	+$13.1K	﹤0.01%	463

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trustmark National Bank Trust Department's GWPH Position: Q3 2019 in Review

Trustmark National Bank Trust Department sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 100 shares — an estimated $17K sold.

Trustmark National Bank Trust Department first reported a position in GWPH in Q4 2018 and held it in 3 quarters. The position peaked at $17K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Trustmark National Bank Trust Department reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Trustmark National Bank Trust Department sold 100 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $17K.
Trustmark National Bank Trust Department first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 3 quarters.
Trustmark National Bank Trust Department's GW Pharmaceuticals Plc American Depositary Shares position peaked at $17K in Q2 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2019, filed 14 Nov 2019.